Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

BRCA1-mediated signaling pathways in ovarian carcinogenesis.

Karve TM, Li X, Saha T.

Funct Integr Genomics. 2012 Mar;12(1):63-79. doi: 10.1007/s10142-011-0251-2.

PMID:
21887486
2.

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.

Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET.

J Natl Cancer Inst. 2002 Jul 3;94(13):990-1000.

PMID:
12096084
3.

Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.

DelloRusso C, Welcsh PL, Wang W, Garcia RL, King MC, Swisher EM.

Mol Cancer Res. 2007 Jan;5(1):35-45.

4.
5.

Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway.

Tanic M, Zajac M, Gómez-López G, Benítez J, Martínez-Delgado B.

Breast Cancer Res Treat. 2012 Jul;134(1):41-51. doi: 10.1007/s10549-011-1905-4.

PMID:
22167321
7.

BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions.

Yarden RI, Papa MZ.

Mol Cancer Ther. 2006 Jun;5(6):1396-404. Review.

8.

BRCA1 regulation of transcription.

Rosen EM, Fan S, Ma Y.

Cancer Lett. 2006 May 18;236(2):175-85. Review.

PMID:
15975711
9.

Implication of BRCA1 gene in breast cancer.

Kachhap SK, Ghosh SN.

Indian J Exp Biol. 2001 May;39(5):391-400. Review.

PMID:
11510120
10.

BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation.

Piek JM, Dorsman JC, Massuger LF, Ansink AC, Weegenaar J, Shvarts A, Kenemans P, Verheijen RH.

Arch Gynecol Obstet. 2006 Oct;274(6):327-31.

PMID:
16826413
12.

BRCA1 and prostate cancer.

Rosen EM, Fan S, Goldberg ID.

Cancer Invest. 2001;19(4):396-412. Review.

PMID:
11405179
13.

BRCA1 gene in breast cancer.

Rosen EM, Fan S, Pestell RG, Goldberg ID.

J Cell Physiol. 2003 Jul;196(1):19-41. Review.

PMID:
12767038
14.

Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.

Konecny M, Milly M, Zavodna K, Weismanova E, Gregorova J, Mlkva I, Ilencikova D, Kausitz J, Bartosova Z.

Breast Cancer Res Treat. 2011 Feb;126(1):119-30. doi: 10.1007/s10549-010-1325-x.

PMID:
21203900
15.

Specific changes in the proteomic pattern produced by the BRCA1-Ser1841Asn missense mutation.

Crugliano T, Quaresima B, Gaspari M, Faniello MC, Romeo F, Baudi F, Cuda G, Costanzo F, Venuta S.

Int J Biochem Cell Biol. 2007;39(1):220-6.

PMID:
17005433
16.

BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells.

Karve TM, Preet A, Sneed R, Salamanca C, Li X, Xu J, Kumar D, Rosen EM, Saha T.

PLoS One. 2012;7(6):e37697. doi: 10.1371/journal.pone.0037697.

17.

Aberrant methylation of breast and ovarian cancer susceptibility gene 1 in chemosensitive human ovarian cancer cells does not involve the phosphatidylinositol 3'-kinase-Akt pathway.

Wang YQ, Zhang JR, Li SD, He YY, Yang YX, Liu XL, Wan XP.

Cancer Sci. 2010 Jul;101(7):1618-23. doi: 10.1111/j.1349-7006.2010.01568.x.

18.

Gene expression: protein interaction systems network modeling identifies transformation-associated molecules and pathways in ovarian cancer.

Bapat SA, Krishnan A, Ghanate AD, Kusumbe AP, Kalra RS.

Cancer Res. 2010 Jun 15;70(12):4809-19. doi: 10.1158/0008-5472.CAN-10-0447.

19.

Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway.

Weberpals JI, Clark-Knowles KV, Vanderhyden BC.

J Clin Oncol. 2008 Jul 1;26(19):3259-67. doi: 10.1200/JCO.2007.11.3902. Review.

PMID:
18591560
20.

Functional analysis of familial Asp67Glu and Thr1051Ser BRCA1 mutations in breast/ovarian carcinogenesis.

Pongsavee M, Patmasiriwat P, Saunders GF.

Int J Mol Sci. 2009 Sep 24;10(9):4187-97. doi: 10.3390/ijms10094187.

Supplemental Content

Support Center